The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tan, J.
Right arrow Articles by Mullan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, J.
Right arrow Articles by Mullan, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 1999, 163: 6614-6621.
Copyright © 1999 by The American Association of Immunologists

Ligation of Microglial CD40 Results in p44/42 Mitogen-Activated Protein Kinase-Dependent TNF-{alpha} Production That Is Opposed by TGF-ß1 and IL-10

Jun Tan1, Terrence Town, Michael Saxe, Daniel Paris, Yajuan Wu and Michael Mullan

The Roskamp Institute, Department of Psychiatry, University of South Florida, Tampa, FL 33613

Recently, it has been demonstrated that the CD40 receptor is constitutively expressed on cultured microglia at low levels. Ligation of CD40 by CD40 ligand on these cells results in microglial activation, as measured by TNF-{alpha} production and neuronal injury. However, the intracellular events mediating this effect have yet to be investigated. We report that ligation of microglial CD40 triggers activation of p44/42 mitogen-activated protein kinase (MAPK). This effect is evident 30 min posttreatment, and progressively declines thereafter (from 30 to 240 min). Phosphorylated p38 MAPK is not observed in response to ligation of microglial CD40 across the time course examined. Inhibition of the upstream activator of p44/42 MAPK, mitogen-activated protein/extracellular signal-related kinase kinase 1/2, with PD98059, decreases phosphorylation of p44/42 MAPK and significantly reduces TNF-{alpha} release following ligation of microglial CD40. Furthermore, cotreatment of microglial cells with CD40 ligand and TGF-ß1 or IL-10, or both, inhibits CD40-mediated activation of p44/42 MAPK and production of TNF-{alpha} in a statistically interactive manner. Taken together, these data show that ligation of microglial CD40 triggers TNF-{alpha} release through the p44/42 MAPK pathway, an effect that can be opposed by TGF-ß1 and IL-10.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. J. Shedlock, J. K. Whitmire, J. Tan, A. S. MacDonald, R. Ahmed, and H. Shen
Role of CD4 T Cell Help and Costimulation in CD8 T Cell Responses During Listeria monocytogenes Infection
J. Immunol., February 15, 2003; 170(4): 2053 - 2063.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Tan, T. Town, T. Mori, Y. Wu, M. Saxe, F. Crawford, and M. Mullan
CD45 Opposes beta -Amyloid Peptide-Induced Microglial Activation via Inhibition of p44/42 Mitogen-Activated Protein Kinase
J. Neurosci., October 15, 2000; 20(20): 7587 - 7594.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Tan, T. Town, and M. Mullan
CD45 Inhibits CD40L-induced Microglial Activation via Negative Regulation of the Src/p44/42 MAPK Pathway
J. Biol. Chem., November 17, 2000; 275(47): 37224 - 37231.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.